Similarly, Zhang et al. found BCL2A1 to be upregulated in the M4 and M5 subtypes of AML, which were also the subtypes with the least sensitivity toward venetoclax [105]. This evidence concerns the gene BCL2A1 and acute myeloid leukemia.